Results 211 to 220 of about 109,449 (270)
Diabetic Medicine, Volume 43, Issue 5, May 2026.Abstract Aims Research to inform, co‐develop and evaluate optimal care for women with early‐onset type 2 diabetes (EOT2D) before, during and after pregnancy is lacking. Informed by patient perspectives and the results of the James Lind Alliance priority‐setting partnership in diabetes in pregnancy, we aimed to develop a consensus statement to guide ...
Sara L. White +8 more
wiley +1 more source
The Multifaceted Role of Keratinocytes in Hidradenitis Suppurativa Pathogenesis
Experimental Dermatology, Volume 35, Issue 5, May 2026.ABSTRACT Hidradenitis suppurativa (HS) is a chronic autoinflammatory skin disorder of the pilosebaceous unit, with multiple factors contributing to its onset, activity and progression. Alongside a predisposing genetic background, hormonal and microbiome alterations, dysregulation of innate and adaptive immune response, as well as environmental ...
Chiara Moltrasio +2 more
wiley +1 more source
Targeting nuclear receptor corepressors for reversible male contraception. [PDF]
Proc Natl Acad Sci U S AHong SH +13 more
europepmc +1 more source
Helicobacter, Volume 31, Issue 3, May/June 2026.ABSTRACT Background Vonoprazan‐based dual therapy has been proposed as a simplified strategy for Helicobacter pylori eradication, but head‐to‐head comparisons of different antibiotic partners are limited. We compared the efficacy, safety, and adherence of vonoprazan‐based dual regimens with those of bismuth‐containing quadruple therapy (BQT).
Jie Li +8 more
wiley +1 more source
Effective delivery of reproductive health services to men: a review study in Kenya and Malawi
, 2001 Dodoo, Francis +2 more
core
Ferritin-nanocaged aggregation-induced emission nanoaggregates for NIR-II fluorescence-guided noninvasive, controllable male contraception. [PDF]
Mater Today BioYu X +13 more
europepmc +1 more source
What About Methods for Men? A Qualitative Analysis of Attitudes Toward Male Contraception in Burkina Faso and Uganda. [PDF]
Int Perspect Sex Reprod Health, 2020 Cartwright AF +3 more
europepmc +1 more source
Low‐Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial
The Journal of Clinical Hypertension, Volume 28, Issue 5, May 2026.ABSTRACT Low‐dose single‐pill combinations (SPCs) are gaining recognition as an efficient therapeutic strategy for mild hypertension. However, evidence from randomized controlled trials regarding the efficacy and safety of half‐dose telmisartan/amlodipine SPCs remains limited.
Hyo‐Suk Ahn +33 more
wiley +1 more source